Roche drug dramatically reduces bleeds in key haemophilia tests

LONDON, May 21 (Reuters) - Roche's new haemophilia drug Hemlibra dramatically reduced bleeding in a broad population of haemophilia patients, results from two clinical trials showed on Monday, setting it up to take a dominant market position.